Recent Finacing
Recent Raise
Taysha Gene Therapies develops intrathecally delivered AAV gene‑replacement therapies for monogenic CNS diseases, advancing multiple clinical-stage programs and partnering with UT Southwestern for discovery, preclinical, clinical and manufacturing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
